Search

Author/Creator Carter, H. Ballentine

12. Multiparametric magnetic resonance imaging findings in men with low‐risk prostate cancer followed using active surveillance. (6th March 2013)

Authors:
Mullins, Jeffrey K.; Bonekamp, David; Landis, Patricia; Begum, Hosne; Partin, Alan W.; Epstein, Jonathan I.; Carter, H. Ballentine; Macura, Katarzyna J.
Journal:
BJU international
Issue:
Volume 111:Number 7(2013:Apr.)
Page Start:
1037
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Outcomes of men with an elevated prostate‐specific antigen (PSA) level as their sole preoperative intermediate‐ or high‐risk feature. (13th August 2014)

Authors:
Faisal, Farzana A.; Sundi, Debasish; Pierorazio, Phillip M.; Ball, Mark W.; Humphreys, Elizabeth B.; Han, Misop; Epstein, Jonathan I.; Partin, Alan W.; Carter, H. Ballentine; Bivalacqua, Trinity J.; Schaeffer, Edward M.; Ross, Ashley E.
Journal:
BJU international
Issue:
Volume 114:Number 6B(2014)
Page Start:
E120
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts. Issue 3 (22nd October 2019)

Authors:
Lange, Jane M.; Laviana, Aaron A.; Penson, David F.; Lin, Daniel W.; Bill‐Axelson, Anna; Carlsson, Sigrid V.; Newcomb, Lisa F.; Trock, Bruce J.; Carter, H. Ballentine; Carroll, Peter R.; Cooperberg, Mathew R.; Cowan, Janet E.; Klotz, Laurence H.; Etzioni, Ruth B.
Journal:
Cancer
Issue:
Volume 126:Issue 3(2020)
Page Start:
583
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Risk prediction tool for grade re‐classification in men with favourable‐risk prostate cancer on active surveillance. (29th August 2016)

Authors:
Mamawala, Mufaddal M.; Rao, Karthik; Landis, Patricia; Epstein, Jonathan I.; Trock, Bruce J.; Tosoian, Jeffrey J.; Pienta, Kenneth J.; Carter, H. Ballentine
Journal:
BJU international
Issue:
Volume 120:Number 1(2017)
Page Start:
25
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Serum prostate‐specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density. (7th June 2013)

Authors:
Umbehr, Martin H.; Platz, Elizabeth A.; Peskoe, Sarah B.; Bhavsar, Nrupen A.; Epstein, Jonathan I.; Landis, Patricia; Partin, Alan W.; Carter, H. Ballentine
Journal:
BJU international
Issue:
Volume 113:Number 4(2014:Apr.)
Page Start:
561
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Serum prostate‐specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density. (7th June 2013)

Authors:
Umbehr, Martin H.; Platz, Elizabeth A.; Peskoe, Sarah B.; Bhavsar, Nrupen A.; Epstein, Jonathan I.; Landis, Patricia; Partin, Alan W.; Carter, H. Ballentine
Journal:
BJU international
Issue:
Volume 113(2014)Supplement 4
Page Start:
561
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗